SciELO - Scientific Electronic Library Online

 
vol.17 issue1Effect of bio-inoculant from microbial consortia phosphate solubilizing natives in development of pastures (Dichantium aristatum)Cultivation of Arthrospira platensis (Spirulina) in curved doubly tubular photobioreactor to environmental conditions in the South of the Peru author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Biotecnología

Print version ISSN 0123-3475

Abstract

SALAZAR GARCIA, Aída; CRUZ JIMENEZ, Elicet; LLOVERAS MACIA, Joaquim  and  URRIOLAGOITIA CALDERON, Guillermo. Proceed to the innovation in the pharmaceutical industry. The case of Spain. Rev. colomb. biotecnol [online]. 2015, vol.17, n.1, pp.131-141. ISSN 0123-3475.  http://dx.doi.org/10.15446/rev.colomb.biote.v17n1.50691.

This article explores sectors identified innovation in Spanish pharmaceutical companies. It also considers domestic firms and foreign subsidiaries in the country. The analysis covers the period 2009 to 2011 for a population N=200 affiliates at that time Farmaindustria and Plan Profarma. The work involved a search of useful information on the websites of pharmaceutical companies based in Spain statically describes the innovative profile of the Spanish pharmaceutical through descriptive statistical analysis. Thus a foundation for documenting the results in a database in order to get a picture with determination on the behavior of Spanish pharmaceutical sector and possible trends is created. The high content of literary contribution on the pharmaceutical sector is expressed in a globalized national and international level, rejecting data and information that could provide signals threat or opportunity regarding short period time, and which in turn are comparable to other years since the Spanish pharmaceutical industry is constituted by companies of foreign origin (50.5%) and domestic capital (49.5%). Of the latter SMEs are the protagonists of small innovations established in Madrid and Barcelona mainly.

Keywords : innovation; pharmaceutical industry; R&D; companies.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )